Back to Results

Calipharms Inc (KGET)

CaliPharms, Inc. (OTC: KGET) is a common stock listing for a company focused on the medicinal cannabis sector in the United States. Its business emphasis is on beverages containing THC and CBD, placing it within the broader cannabis-related consumer products space. The company was previously known as Kleangas Energy Technologies, Inc. and adopted the CaliPharms name in January 2017. CaliPharms is based in Temecula, California.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-KGET
—
—
—
—
—
—
Fair
—
—
—
0.0%
—
—
—
—
13.876 K
—
—
—
—
—
—
Send a message
Valuation • Fair Value

Calipharms Inc (OTC-KGET) Fair Value by Valuation Model

Compare the primary fair value estimate for Calipharms Inc (OTC-KGET) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

Not available

Data is currently unavailable.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

NM

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Calipharms Inc (OTC-KGET) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Calipharms Inc (OTC-KGET)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

Not available

Data is currently unavailable.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Calipharms Inc (OTC-KGET) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Calipharms Inc (OTC-KGET)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

Not available

Data is currently unavailable.

Beneish M-Score

Not available

Data is currently unavailable.

Altman Z-Score

Not available

Data is currently unavailable.

FCF / Net Income

Not available

Data is currently unavailable.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Calipharms Inc (OTC-KGET). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Calipharms Inc (OTC-KGET)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

Not available

Days to Earnings

Not available

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Calipharms Inc (OTC-KGET), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Calipharms Inc (OTC-KGET) Stock Forecast & Technical Outlook

Review Calipharms Inc (OTC-KGET) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Calipharms Inc (OTC-KGET) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Calipharms Inc (OTC-KGET) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Calipharms Inc (OTC-KGET) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Calipharms Inc (OTC-KGET) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Calipharms Inc (OTC-KGET) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Calipharms Inc (OTC-KGET)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Calipharms Inc (OTC-KGET) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Calipharms Inc (OTC-KGET) Stock FAQ

Quick answers about Calipharms Inc (OTC-KGET) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
Not available
Data is currently unavailable
Valuation Rating
Not available
Classification is not available
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

A fair value estimate for Calipharms Inc (OTC-KGET) is not currently available in the latest data file.

A clear undervalued or overvalued classification is not currently available in the latest data file.

An analyst price target for Calipharms Inc (OTC-KGET) is not currently available in the latest data file.

The current financial health read for Calipharms Inc (OTC-KGET) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.0%.

The current market capitalization listed for Calipharms Inc is 13.876 K.

The ticker symbol for Calipharms Inc is OTC-KGET, and the stock is listed on OTC Markets.

Calipharms Inc (OTC-KGET) is listed on OTC Markets.

Similar Machinery Stocks on OTC Markets View more

Atlas Copco AB (ATLKY) Atlas Copco AB (ATLKY)
Atlas Copco ADR (ATLCY) Atlas Copco ADR (ATLCY)
Mitsubishi Heavy Industries, Ltd. (MHVYF) Mitsubishi Heavy Industries, Ltd. (MHVYF)
Volvo AB ADR (VLVLY) Volvo AB ADR (VLVLY)
Volvo, AB ser. B (VOLVF) Volvo, AB ser. B (VOLVF)
Sandvik AB ADR (SDVKY) Sandvik AB ADR (SDVKY)
Fanuc Corporation (FANUY) Fanuc Corporation (FANUY)
Komatsu Ltd (KMTUY) Komatsu Ltd (KMTUY)
Schindler Holding AG (SHLRF) Schindler Holding AG (SHLRF)
Techtronic Industries Ltd ADR (TTNDY) Techtronic Industries Ltd ADR (TTNDY)
KONE Oyj (KNYJF) KONE Oyj (KNYJF)
Kone Oyj ADR (KNYJY) Kone Oyj ADR (KNYJY)
SMC Corp (SMECF) SMC Corp (SMECF)
SMC Corp Japan (SMCAY) SMC Corp Japan (SMCAY)
Alfa Laval AB ADR (ALFVY) Alfa Laval AB ADR (ALFVY)
Wartsila Oyj Abp ADR (WRTBY) Wartsila Oyj Abp ADR (WRTBY)
Kubota Corp ADR (KUBTY) Kubota Corp ADR (KUBTY)
IHI Corp ADR (IHICY) IHI Corp ADR (IHICY)
Ebara Corp ADR (EBCOY) Ebara Corp ADR (EBCOY)
Metso Outotec Corp OTC (OUKPY) Metso Outotec Corp OTC (OUKPY)
Kawasaki Heavy Industries Ltd ADR (KWHIY) Kawasaki Heavy Industries Ltd ADR (KWHIY)
Sinotruk Hong Kong Ltd ADR (SHKLY) Sinotruk Hong Kong Ltd ADR (SHKLY)
AB SKF (SKFRY) AB SKF (SKFRY)
ZoomLion (ZLIOY) ZoomLion (ZLIOY)